The calculation of ligand charges in PDB2PQR is based on the partial equalization of orbital electronegativities (PEOE) procedure developed by Gasteiger and Marsili (26 ). In the PEOE procedure, orbital electronegativities χ are linked to partial atomic charges q by a polynomial expansion (χ = a +b·q + c·q2 + d·q3). The coefficients a, b, c and d were optimized by Gasteiger and Marsili using gas phase data on ionization potentials and electron affinities. We utilize a PEOE algorithm, which has been optimized by Czodrowski et al. to obtain better agreement between theoretical and experimental solvation energies for a set of small molecules including the polar amino acids (27 (link)). The resulting PEOE_PB charges have been tested for small-molecule complexes with trypsin, thrombin (28 (link)) and HIV protease (29 ), and have been found to give results that are in agreement with experimental values.
Thrombin
It plays a crucial role in the conversion of fibrinogen to fibrin, leading to the formation of a fibrin clot.
Thrombin also activates other factors, such as Factors V, VIII, and XIII, further enhancing the clotting process.
Regulation of thrombin activity is essential for maintaining a balanced hemostatic system, as excessive or inappropriate thrombin generation can lead to thrombotic disorders.
Proper understanding and optimization of thrombin research protocols are crucial for advancing our understanding of hemostasis and developing effective therapeutic interventions.
Most cited protocols related to «Thrombin»
The calculation of ligand charges in PDB2PQR is based on the partial equalization of orbital electronegativities (PEOE) procedure developed by Gasteiger and Marsili (26 ). In the PEOE procedure, orbital electronegativities χ are linked to partial atomic charges q by a polynomial expansion (χ = a +b·q + c·q2 + d·q3). The coefficients a, b, c and d were optimized by Gasteiger and Marsili using gas phase data on ionization potentials and electron affinities. We utilize a PEOE algorithm, which has been optimized by Czodrowski et al. to obtain better agreement between theoretical and experimental solvation energies for a set of small molecules including the polar amino acids (27 (link)). The resulting PEOE_PB charges have been tested for small-molecule complexes with trypsin, thrombin (28 (link)) and HIV protease (29 ), and have been found to give results that are in agreement with experimental values.
Most recents protocols related to «Thrombin»
Example 2
Recombinant human fascin 1 was expressed as a GST fusion protein in BL21 Escherichia coli. One liter of 2YT medium with ampicillin was inoculated overnight with 3 mL of BL21/DE3 culture transformed with pGEX4T-fascin 1 plasmid and grown at 37° C. until attenuance at 600 nm (D600) reached about 0.8. The culture was then transferred to 18° C. and induced by the addition of 0.1 mM isopropyl β-d-thiogalactoside (IPTG) for 12 h. Bacteria were harvested by centrifugation at 5,000 r.p.m. for 10 min. The pellets were suspended in 30 mL of PBS supplemented with 0.2 mM PMSF, 1 mM DTT, 1% (v/v) Triton X-100 and 1 mM EDTA. After sonication, the suspension was centrifuged at 15,000 r.p.m. for 30 min to remove the cell debris. The supernatant was then incubated for 2 h with 4 mL of glutathione beads (Sigma) at 4° C. After extensive washing with PBS, the beads were resuspended in 10 mL of thrombin cleavage buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM CaCl2, 1 mM DTT). Fascin was released from the beads by incubation overnight with 40-100 U of thrombin at 4° C. After centrifugation, 0.2 mM PMSF was added to the supernatant to inactivate the remnant thrombin activity. The fascin protein was further concentrated with a Centricon® (Boca Raton, FL) filter to about 50 mg/mL.
Example 2
Recombinant human fascin 1 was expressed as a GST fusion protein in BL21 Escherichia coli. One liter of 2YT medium with ampicillin was inoculated overnight with 3 mL of BL21/DE3 culture transformed with pGEX4T-fascin 1 plasmid and grown at 37° C. until attenuance at 600 nm (D600) reached about 0.8. The culture was then transferred to 18° C. and induced by the addition of 0.1 mM isopropyl β-d-thiogalactoside (IPTG) for 12 h. Bacteria were harvested by centrifugation at 5,000 r.p.m. for 10 min. The pellets were suspended in 30 mL of PBS supplemented with 0.2 mM PMSF, 1 mM DTT, 1% (v/v) Triton X-100 and 1 mM EDTA. After sonication, the suspension was centrifuged at 15,000 r.p.m. for 30 min to remove the cell debris. The supernatant was then incubated for 2 h with 4 mL of glutathione beads (Sigma) at 4° C. After extensive washing with PBS, the beads were resuspended in 10 mL of thrombin cleavage buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM CaCl2), 1 mM DTT). Fascin was released from the beads by incubation overnight with 40-100 U of thrombin at 4° C. After centrifugation, 0.2 mM PMSF was added to the supernatant to inactivate the remnant thrombin activity. The fascin protein was further concentrated with a Centricon® (Boca Raton, FL) filter to about 50 mg/mL.
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
In addition, we measured the dynamics of white blood cell (WBC) count, C-reactive protein (CRP, mg/l), and platelet count (109/l) from the same time points. Preoperative plasma values of prothrombin time (Medirox Owren's PT [%] Medirox, Nyköping, Sweden), FXIII (F-XIII, %), VWF antigen (VWF:Ag, %) and VWF glycoprotein GPIb binding activity (VWF:Act, %), homocysteine (Hcyst, µmol/l), low-density lipoprotein (mmol/l), and triglycerides (Trigly, mmol/l) were collected. Additionally, patients were screened for protein C and S deficiencies, antiphospholipid antibodies as well as Factor V Leiden and FII G20210A mutations.
Top products related to «Thrombin»
More about "Thrombin"
It is responsible for the conversion of fibrinogen to fibrin, a crucial step in the formation of a fibrin clot.
This enzymatic reaction is key to maintaining hemostasis, the balanced regulation of blood clotting.
Thrombin also activates other coagulation factors, such as Factors V, VIII, and XIII, further enhancing the clotting process.
Proper understanding and optimization of thrombin research protocols are essential for advancing our knowledge of hemostasis and developing effective therapeutic interventions for thrombotic disorders.
Bovine thrombin and human thrombin are commonly used in research settings, while aprotinin is a serine protease inhibitor that can regulate thrombin activity.
Bovine fibrinogen and human fibrinogen are also important substrates in thrombin-mediated clot formation.
Bovine serum albumin is often used as a stabilizing agent in thrombin-based experiments.
By leveraging AI-driven tools like PubCompare.ai, researchers can streamline their thrombin research workflows, identify the best protocols and products, and enhance the reproducibility and accuracy of their studies.
This innovative approach helps advance our understanding of this critical coagulation factor and its role in hemostasis and thrombotic disorders.